had a mean stone size 51 mm +/-22 s.d. (range 13-72 mm). Stones were single in 55%, multiple/staghorn in 45% of cases, with 24% coexistent ureteral stones. Mean operative time was 88 minutes +/-35 s.d., including patient positioning. Preliminary semirigid ureteroscopy was performed in 81% of cases, additional flexible ureteroscopy in 53%. Endovision aid to fluoroscopy/ultrasound renal access (90% inferior calyx, 94% single access) was possible in 39% of cases. Retrograde ureteroscopy (ureteral stone treatment, in situ lithotripsy, stone fragments retrieval in calyces parallel to the access tract,.) had an active role in 54% of cases. The stone-free rate was 89.8%, 94.3% after an early second percutaneous look during the same hospital stay. The overall complication rate was 7.4% (1.6% of cases Clavien 3 and never more, no ureteral lesions). Mean fluoroscopy time of the 'reallyendoscopic' cases was 3.3 minutes +/-1.2 s.d., versus 5.5 +/-3 s.d. of the other ECIRS.
INTRODUCTION AND OBJECTIVES: Glans necrosis following penile implant is a very rare complication. The literature has a paucity of information with only 5 single case reports. Glans necrosis is devastating to both patient and physician. The blood supply of the glans penis is twofold: dorsal penile arteries and corpus spongiosum muscle. Glans necrosis initially presents with a dusky, sometimes blistered glans on first post op day. The dilemma of immediate implant removal or continued observation perplexed each surgeon.
METHODS: The patients were collected from the experience of large volume implanters in 7 countries. We report 19 cases following prosthesis implantation (8 rods, 11 inflatable) examining etiology and treatment outcomes with the hope of both prevention & optimum treatment suggestion. From this patient population we compiled risk factors and adjunctive surgical maneuvers that might compromise vascularity of the Glans Penis. 7 of the patients had pre-operative Doppler showing arterial patency of the dorsal arteries. Risk factors detected were: Severe arteriosclerotic cardiovascular disease (ASCVD) (84%) Diabetes (84%) Smoking (72%) Previous removal of implant usually for infection (68%) Radiation Therapy (56%) 79% of patients had 60% of these comorbidities. 53% of patients had 80% risk factors Surgical maneuvers found in the population during prosthesis placement were Subcoronal incision for coincident circumcision or penile degloving (89%) Penile wrap with elastic bandage (74%) Coincident distal urethral injury &/or repair (28%) Sliding procedure for penile lengthening (28%) RESULTS: 15 (79%) patients had expectant management i.e., implant preservation & observation. All sustained significant loss of glans; most required relocation of urethral meatus. 4 (21%) patients were managed with immediate prosthesis removal and hyperbaric oxygen. All healed without sequelae.
CONCLUSIONS: Prospective implant patients with many of the risk factors -diabetes, smoking, radiation therapy, previous implant removal, & severe ASCVD -should not undergo coincident subcoronal incision for circumcision, distal urethral repair, or penile lengthening. Occlusive elastic penile bandage should be avoided. Upon development of signs of glans ischemia, immediate implant removal is mandatory for prevention of glans necrosis. With the growing epidemic of opioid abuse there is a increased focus on prescribing narcotic analgesics. Surgeons must consider ways to limit these prescriptions. Placement of an inflatable penile prosthesis (IPP) for refractory erectile dysfunction (ED) has high satisfaction rates (92-100% ), but is associated with significant postoperative pain usually requiring opioid analgesics for 7-10 days. Use of bupivacaine liposome injectable suspension has been shown to provide a reduction in postoperative pain and opioid use, although nearly 100 times more expensive than bupivacaine HCl. Our objective was to evaluate the feasibility of a long acting preoperative local anesthetic block in discharging patients on postoperative day (POD) 0 after IPP placement without an opioid prescription and to demonstrate ease of administration.
METHODS: 85 men underwent IPP placement for refractory ED with a local penoscrotal block. A mixture of 0.5% ropivacaine 20cc, 1% lidocaine 20cc, sodium bicarbonate 1cc, and dexamethasone 4mg was prepared prior to administration. The local anesthetic block was given using a 22-gauge needle into the pudendal space bilaterally, subcutaneous penile ring, and the external inguinal ring. The IPP was placed using a modified no touch technique through a subcoronal (88%), infrapubic (11%), or penoscrotal (1%) approach.
RESULTS: In addition to local penoscrotal block, 27 (32%) and 58 (68%) patients received general anesthesia and monitored anesthesia care respectively. The Wong-Baker FACES Visual Analog Scale was used to evaluate pain in the recovery room with an average score of 4.4 (range 0-6). All patients were discharged home on POD 0 with a prescription for Acetaminophen or NSAIDs; none were prescribed opioids. Patients were evaluated on POD 2 and, 9 (11%) patients required a prescription for opioid analgesics. However, at POD 7-10 days, no patients were taking opioids. To reinforce the ease of administration, we are currently analyzing resident administration of the local anesthetic block.
CONCLUSIONS: Use of preoperative local penoscrotal block allows for discharge home on POD 0 without opioid analgesics after IPP placement. This local anesthetic mixture is more cost effective than bupivacaine liposome injectable suspensions. With proven efficacy in IPP placemen this local penoscrotal block could be adopted for other penoscrotal surgeries. As opioid addiction and overdose continues to be a public health concern, innovative techniques such as we describe to limit postoperative narcotic requirements are paramount. Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e441
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